Terence Fullerton

Disease progression meta‐analysis model in Alzheimer's disease

Kaori Ito, Sima Ahadieh, Brian Corrigan et al. · Alzheimer s & Dementia · 2009 · 184 citations

Medicine, Neurology, Pharmacology +17

Disease progression model for cognitive deterioration from Alzheimer's Disease Neuroimaging Initiative database

Kaori Ito, Brian Corrigan, Qinying Zhao et al. · Alzheimer s & Dementia · 2010 · 140 citations

Medicine, Biostatistics, Neurology +17

Pharmacokinetics, Safety, and Tolerability After Single and Multiple Oral Doses of Varenicline in Elderly Smokers

Aaron H. Burstein, Terence Fullerton, David J. Clark et al. · The Journal of Clinical Pharmacology · 2006 · 53 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Pharmacokinetic and Pharmacodynamic Effects of a γ‐Secretase Modulator, <scp>PF</scp>‐06648671, on <scp>CSF</scp> Amyloid‐β Peptides in Randomized Phase I Studies

Jae Eun Ahn, Charles Carrieri, Fernando Dela Cruz et al. · Clinical Pharmacology & Therapeutics · 2019 · 35 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer’s disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil

Terence Fullerton, Brendon Binneman, William David et al. · Alzheimer s Research & Therapy · 2018 · 33 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17